可降解无覆膜自膨式支架治疗慢性胰腺炎胰管狭窄的初步验证
这项原理验证研究纳入至少6个月塑料支架内镜扩张失败的慢性胰腺炎胰管狭窄患者,置入无覆膜可降解自膨式支架(BD-SES),主要观察置入成功率和安全性。19例均成功置入且无不良事件,11例(技术成功率58%)狭窄解除,10例(临床成功率52%)无需进一步胰管引流;作者认为BD-SES安全且能解除纤维性狭窄,但结果需进一步验证。
要点
- 19例慢性胰腺炎胰管狭窄患者均成功置入BD-SES,无不良事件。
- 11例(技术成功率58%)狭窄解除,10例(临床成功率52%)无需进一步胰管引流。
- 2例出现支架内淤泥和结石堵塞,经球囊清扫处理;作者认为结果需进一步验证。
核心结论
- 这些初步结果表明BD-SES使用安全,能够解除慢性胰腺炎中的纤维性胰管狭窄。
- 这些令人鼓舞的结果需要进一步验证。
研究设计与样本
- 原理验证研究,纳入至少6个月塑料支架内镜扩张未能解除胰管狭窄的慢性胰腺炎患者。
- 置入无覆膜BD-SES,预期在3至6个月内降解,患者每3个月随访一次、共随访1年。
- 主要结局指标为置入成功率和安全性。
主要发现
- BD-SES在全部19例患者中成功置入,无不良事件。
- 2例发生支架内淤泥和结石堵塞,经球囊清扫处理;其中1枚支架在该操作中解体,随后恢复置入塑料支架。
- 2例观察到增生反应,但未导致功能性梗阻。
- 11例实现狭窄解除(技术成功率58%);6例需进一步治疗胰管狭窄,其中4例内镜、2例手术。
- 另有3例因其他原因手术:2例因慢性胰腺炎相关不良事件行Whipple手术,1例因导管内乳头状黏液性肿瘤行胰尾切除;其余10例无需进一步胰管引流(临床成功率52%)。
局限性
- 作者称这些结果为初步结果,并指出这些令人鼓舞的结果需要进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: In chronic pancreatitis (CP), fibrotic pancreatic duct (PD) strictures pose a therapeutic challenge, because endoscopic dilatation requires multiple procedures with suboptimal results. Biodegradable self-expandable stents (BD-SESs) may serve as an alternative in this setting. METHODS: Patients with CP were eligible for this proof-of-principle study if at least 6 months of endoscopic dilatation with plastic stents had failed to resolve their PD stricture. The non-covered BD-SESs were expected to degrade within 3 to 6 months. Patients were followed at 3-monthly intervals for 1 year. Placement success and safety were the primary outcome parameters. Stricture resolution was assessed by ERCP after 6 months. RESULTS: BD-SESs were successfully placed in all 19 patients without adverse events. In 2 cases, stent occlusion with sludge and stones was treated by a balloon swipe. One stent disintegrated during this procedure, after which placement of the plastic stent was resumed. A hyperplastic response was observed in 2 patients but did not result in functional obstruction. Stricture resolution was accomplished in 11 patients (technical success rate 58%). Six patients required further treatment of their PD stricture, 4 endoscopically and 2 surgically. Three additional patients underwent surgery for other reasons: 2 Whipple procedures for CP-related adverse events and one tail resection for an intraductal papillary mucinous neoplasm. The remaining 10 patients did not require further PD drainage (clinical success rate 52%). CONCLUSIONS: These preliminary results show that BD-SESs are safe to use and able to resolve fibrotic PD strictures in CP. These encouraging outcomes warrant further testing.
引用
- Cahen DL, van der Merwe SW, Laleman W, et al. A biodegradable non-covered self-expandable stent to treat pancreatic duct strictures in chronic pancreatitis: a proof of principle. Gastrointest Endosc. 2017. PMID: 28843580. doi:10.1016/j.gie.2017.08.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。